Smoltek has received an order to perform proof-of-concept study for medtech devices
This press release is an English version of the previously published Swedish version, which has interpretive precedence.
Smoltek Nanotech Holding AB (“Smoltek”) announces that the company has received an order, worth 40,000 euros, to perform a proof-of-concept study using the company’s unique carbon nanofiber technology in solving a difficult materials engineering problem for a global medtech company.
The purpose of the proof-of-concept study is to confirm that Smoltek’s electrically conductive, vertically aligned carbon nanofibers can function as an interconnect between an integrated circuit and a sensor material that is not compatible with metals.
“This is a great business opportunity for us, in a unique context where we don’t really see any alternative solutions. The medtech industry is very interesting as a potential business area for Smoltek’s future expansion, in addition to our two priority business areas: the semiconductor industry, where we develop ultra-thin capacitors for application processors and the hydrogen industry, where we develop high-performance cell materials for electrolyzers”, says Håkan Persson, CEO of Smoltek Nanotech Holding AB.
Smoltek has been collaborating with the global medical technology company for some time and a number of initial tests have already been performed. The current proof-of-concept study will include a more complete test of the concept, which among other things aims to verify the performance of the solution and to ensure that the assembly lasts, as well as to obtain more knowledge in how to scale up the concept to volume production.
The carbon nanofiber technology used is very similar to the one that Smoltek is developing for its main business track for ultra-thin capacitors, and the proof-of-concept study is an excellent example of one of the many areas where the company’s technology can be applied. The order to carry out the proof-of-concept study is worth 40,000 euros.
For further information:
Håkan Persson, CEO of Smoltek Nanotech Holding AB,
E-mail: hakan.persson@smoltek.com
Phone: +46 760 52 00 53
Website: www.smoltek.com/investors
Smoltek develops process technology and concepts for applications based on carbon nanotechnology to solve advanced materials engineering problems in several industrial sectors. The company protects its unique technology through an extensive and expanding patent portfolio consisting of around 100 applied for patents, of which today 76 have been granted. Smoltek's share is listed on the Spotlight Stock Market in Stockholm, Sweden under the ticker SMOL. Smoltek is a development company, and forward-looking statements regarding time to market, production volume and price levels should be interpreted as forecasts and not commitments.